BioCentury
ARTICLE | Company News

Forbes, Pharmachem Laboratories Inc. deal

September 6, 2010 7:00 AM UTC

Supplement company Pharmachem completed its previously announced acquisition of substantially all Forbes' assets for $4 million in cash. Forbes anticipates distributing C$0.50-C$0.58 per share to its ...